Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

409
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
409
Gallbladder01:17

Gallbladder

270
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
270
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

295
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
295

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to: Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review.

Current diabetes reviews·2026
Same author

High throughput screening of nuclear receptors identifies NR4A1 as a novel tumor suppressor in gallbladder cancer.

International journal of biological macromolecules·2026
Same author

Meta-analysis of Early Risk Factors Associated with Cerebrovascular Diseases.

Current neurovascular research·2026
Same author

Port Site Excision During Completion Extended Cholecystectomy for Incidental Gallbladder Cancer - A Scoping Review.

Journal of gastrointestinal cancer·2026
Same author

Role of Cystic Lymph Nodes in Incidental Gallbladder Cancer: Implications for Routine Excision and the Sentinel Lymph Node Concept.

Cureus·2026
Same author

Banker Type of Juvenile Dermatomyositis.

Indian journal of dermatology·2025

Related Experiment Video

Updated: May 21, 2025

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.6K

Serum Aflatoxin B1-Lysine Adduct Concentration and Gallbladder Cancer: A Case-Control Study.

Ratnakar Shukla1, Toshikazu Ikoma2, Yasuo Tsuchiya3

  • 1Department of Clinical Research, Sharda School of Allied Health Sciences, Sharda University, Greater Noida, Uttar Pradesh, 201306, India.

Nutrition and Cancer
|March 19, 2025
PubMed
Summary

Aflatoxin B1 (AFB1) exposure is linked to gallbladder cancer (GBC). GBC patients showed significantly higher serum AFB1 levels than chronic cholecystitis patients or healthy individuals, suggesting a potential risk factor.

More Related Videos

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.1K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.0K

Related Experiment Videos

Last Updated: May 21, 2025

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.6K
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

11.1K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.0K

Area of Science:

  • Toxicology
  • Gastroenterology
  • Oncology

Background:

  • Aflatoxin B1 (AFB1) is a known carcinogen, primarily associated with liver cancer.
  • Emerging evidence suggests a potential link between AFB1 exposure and gallbladder cancer (GBC).

Purpose of the Study:

  • To investigate the association between serum AFB1 levels and GBC.
  • To compare AFB1 levels in GBC patients with those in chronic cholecystitis (CC) patients and healthy subjects (HS).

Main Methods:

  • Serum samples were collected from 45 GBC patients, 57 CC patients, and 55 HS.
  • Serum AFB1-lysine adduct levels were quantified using ELISA.
  • Detection frequency and levels were compared across the three groups.

Main Results:

  • AFB1 was detected in 71% of GBC patients, 39% of CC patients, and 7% of HS (p < 0.001).
  • The odds of AFB1 detection were significantly higher in GBC patients compared to CC patients (4.1x) and HS (16.8x).
  • Median serum AFB1 levels were substantially higher in GBC patients (5.0 ng/mL) versus CC patients (<0.1 ng/mL) and HS (<0.1 ng/mL).

Conclusions:

  • Direct evidence suggests AFB1 exposure is associated with an increased risk of developing GBC in India.
  • Elevated serum AFB1 levels serve as a potential biomarker for GBC risk.
  • Further research is warranted to elucidate the mechanisms underlying AFB1-induced GBC.